Graduate Student Awards in Asthma - April 16, 2025
​​​
​
Research Grant in HAE - April 30, 2025​​
​
Fellowship/Early Investigator Award in Primary Immunodeficiency - May 22, 2025
Graduate Student Awards in Asthma​
Applications due: April 16, 2025 at 11:59 pm in the time zone of the applicant
​
The objective of the Graduate Student Awards in Asthma is to create value-added opportunities for the training, education and professional development of graduate students, to promote greater understanding of the causes, and mechanisms of asthma with a view towards improvement of asthma treatments and potential cures.
There are a minimum of two (2) awards for PhD students valued at $30,000 each and a minimum of one (1) award for MSc students valued at $15,000 each.
​
Click here for eligibility and to apply online​.
This award is supported by Asthma Canada and CAAIF.
CASP-CAAIF-KalVista Research Grant in Hereditary Angioedema (HAE)
Applications due: April 30, 2025 at 11:59 pm in the time zone of the applicant
​
The objective of the CASP-CAAIF-KalVista Research Grant in Hereditary Angioedema (HAE) is to fund a research focused on HAE which can include Types 1, 2, and C1 Normal.
The maximum value of the Award is $50,000.
​
Click here for eligibility and to apply online​.
This award is supported by CAAIF, the Canadian Angioedema Scholarship Program (CASP) and KalVista Pharmaceuticals
CAAIF-Immunodeficiency Canada Fellowship/Early Investigator Award in Primary Immunodeficiency
Applications due: May 22, 2025 at 11:59 pm in the time zone of the applicant
​
The objective of the CAAIF-Immunodeficiency Canada Fellowship/Early Career Investigator in Primary Immunodeficiency is to support fellows and early career investigators doing research into advancement of knowledge into understanding the molecular and genetic basis of primary immunodeficiency as well as breakthroughs in novel treatments for these conditions.
The maximum value of the Award is $20,000.
​
Click here for eligibility and to apply online​.
This award is supported by CAAIF and Immunodeficiency Canada